Annual EBIT
-$69.40 M
-$5.38 M-8.41%
December 31, 2023
Summary
- As of February 7, 2025, OCUL annual earnings before interest & taxes is -$69.40 million, with the most recent change of -$5.38 million (-8.41%) on December 31, 2023.
- During the last 3 years, OCUL annual EBIT has risen by +$79.47 million (+53.38%).
- OCUL annual EBIT is now -58911.86% below its all-time high of $118.00 thousand, reached on December 31, 2021.
Performance
OCUL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$33.27 M
+$7.31 M+18.02%
September 30, 2024
Summary
- As of February 7, 2025, OCUL quarterly earnings before interest & taxes is -$33.27 million, with the most recent change of +$7.31 million (+18.02%) on September 30, 2024.
- Over the past year, OCUL quarterly EBIT has dropped by -$36.18 million (-1243.26%).
- OCUL quarterly EBIT is now -793.10% below its all-time high of $4.80 million, reached on March 31, 2021.
Performance
OCUL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$159.72 M
-$36.18 M-29.29%
September 30, 2024
Summary
- As of February 7, 2025, OCUL TTM earnings before interest & taxes is -$159.72 million, with the most recent change of -$36.18 million (-29.29%) on September 30, 2024.
- Over the past year, OCUL TTM EBIT has dropped by -$101.69 million (-175.25%).
- OCUL TTM EBIT is now -134315.13% below its all-time high of $119.00 thousand, reached on December 31, 2021.
Performance
OCUL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
OCUL EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.4% | -1243.3% | -175.3% |
| 3 y3 years | +53.4% | -871.0% | -95.7% |
| 5 y5 years | -19.2% | -94.3% | -99.0% |
OCUL EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | at low | -1243.3% | +45.3% | <-9999.0% | at low |
| 5 y | 5-year | <-9999.0% | +53.4% | -793.1% | +60.3% | <-9999.0% | at low |
| alltime | all time | <-9999.0% | +53.4% | -793.1% | +60.3% | <-9999.0% | at low |
Ocular Therapeutix EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$33.27 M(-18.0%) | -$159.72 M(+29.3%) |
| Jun 2024 | - | -$40.58 M(-33.3%) | -$123.54 M(+21.5%) |
| Mar 2024 | - | -$60.80 M(+142.5%) | -$101.65 M(+46.5%) |
| Dec 2023 | -$69.40 M(+8.4%) | -$25.07 M(-961.5%) | -$69.40 M(+19.6%) |
| Sep 2023 | - | $2.91 M(-115.6%) | -$58.03 M(-30.4%) |
| Jun 2023 | - | -$18.69 M(-34.5%) | -$83.33 M(+2.0%) |
| Mar 2023 | - | -$28.55 M(+108.5%) | -$81.71 M(+27.6%) |
| Dec 2022 | -$64.02 M(<-9900.0%) | -$13.70 M(-38.8%) | -$64.02 M(+22.0%) |
| Sep 2022 | - | -$22.39 M(+31.2%) | -$52.49 M(+103.6%) |
| Jun 2022 | - | -$17.07 M(+57.2%) | -$25.78 M(+65.9%) |
| Mar 2022 | - | -$10.86 M(+400.4%) | -$15.54 M(<-9900.0%) |
| Dec 2021 | $118.00 K(-100.1%) | -$2.17 M(-150.3%) | $119.00 K(-100.1%) |
| Sep 2021 | - | $4.32 M(-163.2%) | -$81.60 M(-15.1%) |
| Jun 2021 | - | -$6.83 M(-242.2%) | -$96.14 M(-22.6%) |
| Mar 2021 | - | $4.80 M(-105.7%) | -$124.19 M(-16.6%) |
| Dec 2020 | -$148.87 M(+85.5%) | -$83.89 M(+720.1%) | -$148.87 M(+66.9%) |
| Sep 2020 | - | -$10.23 M(-70.7%) | -$89.19 M(-7.2%) |
| Jun 2020 | - | -$34.87 M(+75.4%) | -$96.09 M(+14.3%) |
| Mar 2020 | - | -$19.88 M(-17.9%) | -$84.04 M(+4.7%) |
| Dec 2019 | -$80.27 M(+37.8%) | -$24.21 M(+41.4%) | -$80.27 M(+9.8%) |
| Sep 2019 | - | -$17.13 M(-25.0%) | -$73.08 M(+3.6%) |
| Jun 2019 | - | -$22.83 M(+41.7%) | -$70.54 M(+15.5%) |
| Mar 2019 | - | -$16.11 M(-5.4%) | -$61.07 M(+4.9%) |
| Dec 2018 | -$58.24 M | -$17.02 M(+16.7%) | -$58.24 M(+8.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$14.59 M(+9.3%) | -$53.83 M(-0.9%) |
| Jun 2018 | - | -$13.35 M(+0.5%) | -$54.32 M(-8.2%) |
| Mar 2018 | - | -$13.28 M(+5.3%) | -$59.19 M(-3.7%) |
| Dec 2017 | -$61.49 M(+42.9%) | -$12.61 M(-16.3%) | -$61.49 M(+0.3%) |
| Sep 2017 | - | -$15.08 M(-17.3%) | -$61.29 M(+10.7%) |
| Jun 2017 | - | -$18.23 M(+17.0%) | -$55.38 M(+14.9%) |
| Mar 2017 | - | -$15.58 M(+25.6%) | -$48.18 M(+12.0%) |
| Dec 2016 | -$43.02 M(+13.1%) | -$12.40 M(+35.3%) | -$43.02 M(+5.3%) |
| Sep 2016 | - | -$9.17 M(-16.8%) | -$40.85 M(-4.6%) |
| Jun 2016 | - | -$11.03 M(+5.8%) | -$42.80 M(+3.4%) |
| Mar 2016 | - | -$10.42 M(+1.9%) | -$41.37 M(+8.8%) |
| Dec 2015 | -$38.02 M(+38.1%) | -$10.23 M(-8.0%) | -$38.02 M(+7.6%) |
| Sep 2015 | - | -$11.12 M(+15.8%) | -$35.34 M(+13.6%) |
| Jun 2015 | - | -$9.60 M(+35.8%) | -$31.11 M(+12.6%) |
| Mar 2015 | - | -$7.07 M(-6.3%) | -$27.64 M(+0.4%) |
| Dec 2014 | -$27.53 M(+113.8%) | -$7.55 M(+9.7%) | -$27.53 M(+17.7%) |
| Sep 2014 | - | -$6.88 M(+12.2%) | -$23.40 M(+17.3%) |
| Jun 2014 | - | -$6.13 M(-11.9%) | -$19.94 M(+18.8%) |
| Mar 2014 | - | -$6.96 M(+104.0%) | -$16.79 M(+30.4%) |
| Dec 2013 | -$12.88 M(-6.1%) | -$3.41 M(-0.4%) | -$12.88 M(+36.1%) |
| Sep 2013 | - | -$3.43 M(+14.9%) | -$9.46 M(+56.8%) |
| Jun 2013 | - | -$2.98 M(-2.2%) | -$6.03 M(+97.8%) |
| Mar 2013 | - | -$3.05 M | -$3.05 M |
| Dec 2012 | -$13.72 M | - | - |
FAQ
- What is Ocular Therapeutix annual earnings before interest & taxes?
- What is the all time high annual EBIT for Ocular Therapeutix?
- What is Ocular Therapeutix annual EBIT year-on-year change?
- What is Ocular Therapeutix quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly EBIT year-on-year change?
- What is Ocular Therapeutix TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Ocular Therapeutix?
- What is Ocular Therapeutix TTM EBIT year-on-year change?
What is Ocular Therapeutix annual earnings before interest & taxes?
The current annual EBIT of OCUL is -$69.40 M
What is the all time high annual EBIT for Ocular Therapeutix?
Ocular Therapeutix all-time high annual earnings before interest & taxes is $118.00 K
What is Ocular Therapeutix annual EBIT year-on-year change?
Over the past year, OCUL annual earnings before interest & taxes has changed by -$5.38 M (-8.41%)
What is Ocular Therapeutix quarterly earnings before interest & taxes?
The current quarterly EBIT of OCUL is -$33.27 M
What is the all time high quarterly EBIT for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly earnings before interest & taxes is $4.80 M
What is Ocular Therapeutix quarterly EBIT year-on-year change?
Over the past year, OCUL quarterly earnings before interest & taxes has changed by -$36.18 M (-1243.26%)
What is Ocular Therapeutix TTM earnings before interest & taxes?
The current TTM EBIT of OCUL is -$159.72 M
What is the all time high TTM EBIT for Ocular Therapeutix?
Ocular Therapeutix all-time high TTM earnings before interest & taxes is $119.00 K
What is Ocular Therapeutix TTM EBIT year-on-year change?
Over the past year, OCUL TTM earnings before interest & taxes has changed by -$101.69 M (-175.25%)